Cargando...
Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
BACKGROUND: Aberrant activation of fibroblast growth factor receptors (FGFRs) deregulates cell proliferation and promotes cell survival, and may predispose to tumorigenesis. Therefore, selective inactivation of FGFRs is an important strategy for cancer therapy. Here as a proof-of-concept study, we d...
Gardado en:
| Publicado en: | Mol Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4511971/ https://ncbi.nlm.nih.gov/pubmed/26201468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-015-0391-4 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|